• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Incyte Corp (NQ: INCY )

    57.10 -0.56 (-0.97%)
    Streaming Delayed Price Updated: 3:31 PM EDT, Jul 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 827,969
    Open 57.48
    Bid (Size) 57.09 (2)
    Ask (Size) 57.11 (2)
    Prev. Close 57.66
    Today's Range 56.75 - 57.58
    52wk Range 50.27 - 67.36
    Shares Outstanding 222,430,635
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Highly Rated Biotech Stocks for Your July Buy List
    Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street. 
    Via InvestorPlace
    This CrowdStrike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
    Via Benzinga

    Performance

    YTD
    -12.76%
    -12.76%
    1 Month
    -2.51%
    -2.51%
    3 Month
    +3.84%
    +3.84%
    6 Month
    -14.25%
    -14.25%
    1 Year
    -9.35%
    -9.35%

    More News

    Read More
    Stocks Chop As Wall Street Unpacks Powell Comments
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    7 Undervalued Biotech Stocks to Buy for Big-Time Returns
    Via InvestorPlace
    NASDAQ:INCY is not too expensive for the growth it is showing.
    Via Chartmill
    Analyst Expectations For Incyte's Future
    Via Benzinga
    Despite its growth, NASDAQ:INCY remains within the realm of affordability.
    Via Chartmill
    9 Analysts Have This To Say About Incyte
    Via Benzinga
    For those who appreciate value investing, NASDAQ:INCY is a compelling option with its solid fundamentals.
    Via Chartmill
    Nasdaq 100, S&P 500 Close At Record Highs As Tech Stocks Reclaim Dominance: Thursday's Gainers & Losers
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Incyte Announces Final Results of Tender Offer
    From Incyte Corporation
    Via Business Wire
    NASDAQ:INCY is showing decent growth, but is still valued reasonably.
    Via Chartmill
    Incyte Announces Preliminary Results of Tender Offer
    From Incyte Corporation
    Via Business Wire
    Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Incyte
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Incyte Completes Acquisition of Escient Pharmaceuticals
    From Incyte
    Via Business Wire
    When you look at NASDAQ:INCY, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
    Via Chartmill
    Hedge Funds Tweak Portfolios In Q1: Marvell, TD Synnex, AES Get More Love As Focus Shifts To AI
    Via Benzinga
    Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings
    From Incyte
    Via Business Wire
    Incyte to Present at Upcoming Investor Conference
    From Incyte
    Via Business Wire
    Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress
    From Incyte
    Via Business Wire
    Tech Stocks Inch Higher Ahead Of Key Inflation Data, GameStop Skyrockets, Tencent Fuels China Rally: What's Driving Markets Monday?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    GameStop, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock
    From Incyte Corporation
    Via Business Wire
    The 3 Best Biotech Stocks to Buy in May 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.